Company News
Business Development Planning: Donna LaVoie to Moderate BIO Webinar on Jan 18, Discussing ‘Signals from JPM Week for 2024
Donna LaVoie, President and CEO, will be moderating at the Biotechnology Innovation Organization Conference on January 18th, between 2:00 and 3:00 pm ET. Learn about the dynamic shifts within the…
Read MoreLaVoieHealthScience Joins IPREX, A Global Communications Network
BOSTON & NEW YORK – October 19, 2023: LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, is now part of IPREX, the top independent…
Read MoreDonna LaVoie Featured in Life Sciences Global Business Report on the Regulatory Landscape
Donna LaVoie, LaVoieHealthScience CEO and President, was featured in Global Business Report’s United States Life Sciences 2023. In the article, “The Regulatory Landscape: Measuring the Inflation Reduction Act Implications,” Donna…
Read MoreGBR Connect Series – Interview with Donna LaVoie, LaVoieHealthScience – USA Life Sciences
Recently, Donna LaVoie, President & CEO was interviewed by Global Business Reports to discuss many topics ranging from post-pandemic response to the shifting regulartory environment and much more. Read…
Read MoreLaVoieHealthScience Announces Building Company Narrative Workshop at 2023 BIO International Convention
…Preparing Companies for M&A, Partnering, and More BOSTON & NEW YORK, May 18, 2023–LaVoieHealthScience (LHS), an award-winning global health science investor relations and public relations consulting agency focused on advancing…
Read MoreDonna LaVoie featured in Birthing of Giants
Donna LaVoie, our CEO was recently featured in an interview conducted by Lewis Shiff, CEO of the Birthing of Giants program. They delved into her remarkable journey from corporate leadership to…
Read More